F-group (family)
225.1.1.3 HATPase_c
Ligands and drugs
2,398
Member domains
644
with ligand contacts (≤ 4 Å)
26.9% of members
560
with DrugDomain annotations
23.4% of members
340
with a DrugBank compound
14.2% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 225.1.1.3 belongs to X-group 225 ATPase domain of HSP90 chaperone/DNA topoisomerase II/histidine kinase-like, which binds 9.8 ligand superclasses per 20 proteins, broader than 92% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB16833 | ADP | Adenosine disphosphate | 103 |
| DB03909 | ACP | Adenosine-5'-[Beta, Gamma-Methylene]Triphosphate | 41 |
| DB01051 | NOV | Novobiocin | 21 |
| DB00171 | ATP | ATP | 17 |
| DB03758 | RDC | Radicicol | 9 |
| DB09459 | TLA | L-tartaric acid | 6 |
| DB00380 | CDX | Dexrazoxane | 4 |
| DB03900 | TBU | tert-butanol | 3 |
| DB17055 | E0G | SNX-2112 | 3 |
| DB00694 | — | Daunorubicin | 2 |
| DB00997 | — | Doxorubicin | 2 |
| DB02930 | AGS | Adenosine 5'-[gamma-thio]triphosphate | 2 |
| DB03110 | 2CH | 2-Chlorophenol | 2 |
| DB03760 | RED | Dihydrolipoic Acid | 2 |
| DB04417 | NPO | P-Nitrophenol | 2 |
| DB04444 | ALF | Tetrafluoroaluminate Ion | 2 |
| DB05022 | — | — | 2 |
| DB06362 | — | — | 2 |
| DB06421 | — | — | 2 |
| DB08356 | P4A | 4-[4-(4-methoxyphenyl)-5-methyl-1H-pyrazol-3-yl]benzene-1,3-diol | 2 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| MGmetal | MAGNESIUM ION | 250 |
| ADP | ADENOSINE-5'-DIPHOSPHATE | 116 |
| ANP | PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER | 116 |
| ACP | PHOSPHOMETHYLPHOSPHONIC ACID ADENYLATE ESTER | 47 |
| Kmetal | POTASSIUM ION | 43 |
| AX7 | 1H-benzimidazol-2-amine | 40 |
| CL | CHLORIDE ION | 31 |
| ATP | ADENOSINE-5'-TRIPHOSPHATE | 26 |
| NOV | NOVOBIOCIN | 21 |
| CAmetal | CALCIUM ION | 19 |
| NAmetal | SODIUM ION | 13 |
| 19Y | 6-ethyl-4-methoxy-2-(pyridin-3-ylsulfanyl)-7H-pyrrolo[2,3-d]pyrimidine-5-carbaldehyde | 10 |
| RDC | RADICICOL | 9 |
| COmetal | COBALT (II) ION | 8 |
| NImetal | NICKEL (II) ION | 8 |
| ZNmetal | ZINC ION | 8 |
| 80S | 2-[[3,4-bis(chloranyl)-5-methyl-1H-pyrrol-2-yl]carbonylamino]-4-[(1S)-1-phenylethoxy]-1,3-benzothiazole-6-carboxylic acid | 6 |
| TLA | L(+)-TARTARIC ACID | 6 |
| XAM | (1R,4aS,5S,6S,8aR)-5-{[(5S)-1-(3-O-acetyl-4-O-carbamoyl-6-deoxy-2-O-methyl-alpha-L-talopyranosyl)-4-hydroxy-2-oxo-5-(propan-2-yl)-2,5-dihydro-1H-pyrrol-3-yl]carbonyl}-6-methyl-4-methylidene-1,2,3,4,4a,5,6,8a-octahydronaphthalen-1-yl 2,6-dideoxy-3-C-[(1S)-1-{[(3,4-dichloro-5-methyl-1H-pyrrol-2-yl)carbonyl]amino}ethyl]-beta-D-ribo-hexopyranoside | 6 |
| DOO | 6-fluoro-4-[(3aR,6aR)-hexahydropyrrolo[3,4-b]pyrrol-5(1H)-yl]-N-methyl-2-[(2-methylpyrimidin-5-yl)oxy]-9H-pyrimido[4,5-b]indol-8-amine | 5 |